Market Challenges And Opportunities

Global Proton Therapy Market – Driver

Increasing number of healthcare facilities offering proton therapy

Due to the increasing prevalence of cancer, the market' key players are focusing on increasing the number of healthcare facilities through growth strategies such as collaboration as well as acquisition. For instance, on 15 February 2023, Moffitt Cancer Center, a nonprofit cancer treatment and research center located in Canada, and IBA Radiopharma Solutions, a medical technology company and provider of proton therapy solutions for the treatment of cancer, had partnered to bring proton therapy treatment to Speros FL, Moffitt’s 775-acre Global Innovation Center located in Pasco County. Moffitt deploys the IBA' ProteusONE small proton therapy equipment as part of its continuous expansion. Moffitt is the only comprehensive cancer center designated by the National Cancer Institute in Canada.

Global Proton Therapy Market: Restraint

Infrastructural challenges in healthcare facilities

Proton therapy is highly priced and requires advanced infrastructure for installation. Space requirements for a proton center are dependent on the number and size of treatment rooms as well as other medical and patient areas. The space requirement by the proton therapy system is quite larger to install the accelerators to produce a high-energy beam. So, to overcome this companies are taking iniative to proposed a small size innovation techniques for producing high energy photons. For instance, in December 2020, according to an article published by IntechOpen, The University of Texas (Monroe Dunaway) MD Anderson Cancer Center proton facility was the first to be part of a National Cancer Institute (NCI)-designated comprehensive cancer center, which comprised of four rooms within a unit that is 96,000 total square feet. This includes a single beam room with two fixed horizontal lines, one for large volume targets and another for small volume targets (such as structures within the eye) while the other three rooms contain isocentric gantries

Global Proton Therapy Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

The outbreak of Covid-19 on proton therapy had a posirive effects on the market. The widespread distribution of the coronavirus, increased infection rates, and a decline in hospital admissions. Government regulations that were imposed on the area during COVID-19 caused a decline in proton treatment production and manufacturing. The post-pandemic condition in proton therapy, along with rising consumer needs for radiation therapy, will improve advancements in the field during the course of the forecast period. The COVID-19 test appears to have the worst outcomes in people with lung cancer. The disease itself or cancer treatments like radiation and surgery, which target the malignancy, might result in lung damage or reduced lung capacity. For instance, in February 2021, according to an article published in the Journal of Radiology Research and Practice published by Hindawi, the COVID-19 pandemic, impacted the regular supply of proton therapy, determining delay or cancellation of procedures in the pandemic days. After pandemic, the market is surge a growth due to inrease in prevalence of cancer.

Restraints & Challenges: